Insilico Medicine Brings GENTRL AI System to Open Source for Drug Discovery

Insilico Medicine has developed GENTRL, a new artificial intelligence system for drug discovery that dramatically accelerates the process from years to days. "By enabling the rapid discovery of novel molecules and by making GENTRL's source code open source, we are ushering in new possibilities for the creation and discovery of new life-saving medicine for incurable diseases - and making such powerful technology more broadly accessible for the first time to the public."

The post Insilico Medicine Brings GENTRL AI System to Open Source for Drug Discovery appeared first on insideHPC.